Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
BALTIMORE--(BUSINESS WIRE)--At the 73 rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows.
A. Bruker Introduces the proteoElute Next-Generation Nanoflow LC System for Robust, Ultra-Sensitive Proteomics Workflows with Real-time Monitoring
Bruker announces the launch of the proteoElute, a state-of-the-art nanoflow liquid chromatography (LC) system designed for robust and ultra-sensitive multiomics applications. The proteoElute is ideal for single-cell proteomics, immunopeptidomics, microbiome metaproteomics profiling, and many other proteomics methods, ensuring reliable performance even with limited or very complex biological samples.
The proteoElute features innovative TwinScape™ technology, which continuously monitors system health in real-time and runs background diagnostics. This proactive approach alerts users to potential issues, providing peace of mind when working with precious samples.
Engineered for relentless reliability, the proteoElute includes biocompatible ceramic valves, new porous metal filters, and a proprietary trap column that together enhance robustness, chromatographic performance, and permit sample recovery. The new injector and needle wash system reduces carry-over by up to 3x, a critical advantage for confidently avoiding background signals when analyzing ultra-low input samples.
W. Hayes McDonald, Associate Director in the Department of Biochemistry at Vanderbilt University, commented: ' The combination of the new proteoElute UHPLC platform along with updated PepSep Advanced columns and the proteoTrap column allows us the flexibility to perform any state-of-the-art proteomics workflow with highest performance. Its remarkable robustness gives us the confidence to execute all proteomics workflows at scale. '
B. Bruker Introduces PepSep Advanced Columns for Sharper nLC Peaks, Higher Sensitivity and Further Enhanced Peptide and Protein Identifications
For highest sensitivity and performance of the proteoElute nLC system, Bruker introduces a new generation of PepSep Advanced nLC columns, engineered for precision, robustness, and speed. The columns deliver sharper peaks and higher-resolution separations for even deeper proteome coverage and consistent performance with challenging biological samples. In benchmark studies, the PepSep Advanced columns demonstrated approximately 20% improvements in peptide IDs and typically 10% improvements in protein IDs.
Combined with CaptiveSpray Ionization (CSI) emitters, users can extend column lifetime by simply replacing the emitter—ensuring long-term performance and cost efficiency. PepSep columns provide the reliability and depth needed for analyzing complex tissue digests or low-input samples.
Lynn Spruce, the Technical Director at the Children's Hospital of Philadelphia (CHOP-Penn) Proteomic Core Facility, said: 'The new PepSep Advanced columns have proven to be robust, and they consistently deliver reproducible chromatography. They produce sharper, more symmetrical peaks with no observable tailing, resulting typically in 7–8% increases in protein group identifications. Combined with the convenience of interchangeable emitters and reasonable pricing, it has become our go-to nLC column. It's essentially plug-and-play.'
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Could the "Next Nvidia Stock" Actually Be... Nvidia Stock?
There seems at least a solid probability that Nvidia stock still has not just good or even great but amazing growth potential left. Year-over-year earnings growth solidly in the double-digit percentages and a reasonable stock valuation should be all that's needed to keep Nvidia investors very happy. 10 stocks we like better than Nvidia › Many articles have been written over the last year or so about "the next Nvidia (NASDAQ: NVDA) stock," which refers to a stock that has the potential to post incredibly strong gains over at least the medium term, just like the artificial intelligence (AI) chip leader has done. With the risk of sounding like I've lost my mind, I think there's a good case to be made that "the next Nvidia stock" could actually be Nvidia stock. In other words, there seems at least a solid probability that Nvidia stock still has not just good or even great but amazing growth potential left. Think of it as "Nvidia the superstar stock 2.0." I say "at the risk of sounding like I've lost my mind" because I understand the law of large numbers strongly works against my thesis. This "law" basically means that the larger a company becomes, the more difficult it becomes to continue to grow revenue and earnings at a strong pace on a year-over-year percentage basis. And year-over-year earnings (and cash flow) growth is what largely powers stock prices higher. Nvidia is massive. It has a market cap of $3.55 trillion, as of June 18, making it the world's second most valuable publicly traded company, trailing Microsoft by just a sliver. Moreover, Nvidia management expects the company to generate revenue of $45 billion in its fiscal second quarter, which equates to an annual revenue run rate of $180 billion. To be clear -- I think it's highly unlikely that Nvidia will ever again be able to pump out a long consecutive string of year-over-year quarterly earnings growth in the very high double-digit to triple-digit percentages. But I don't think it has to do that in order to deliver stellar returns to investors for some time. Year-over-year earnings growth solidly in the double-digits plus a reasonable stock valuation should be all that's needed to keep investors very happy. What makes me have confidence in the "reasonable valuation" bit? Currently, Nvidia stock's valuation is reasonable by just about every measure, but that has not always been true. (For reference, it's trading at 25.4 times Wall Street's projected forward earnings per share, or EPS, as of June 18. That's an attractive valuation for a company that analysts expect will grow EPS at an average annual rate of 30% over the next five years.) The main reason I think the valuation will likely remain relatively reasonable (at least much of the time) for a while circles back to that law of large numbers. Wall Street analysts and many investors are well aware of this phenomenon, and I think most folks in both those groups will tend to continue to significantly underestimate Nvidia's future earnings growth potential due to thoughts like these: An investor and analyst thought: It's so massive, there's no way it can keep growing earnings much. An investor thought: After its massive run-up, I've missed my chance to buy Nvidia stock. (How many of us thought that about, say, Amazon many years ago, only to be proven wrong?) Consistent beliefs like these will help keep Nvidia stock's valuation reasonable in part because Wall Street analysts are going to tend to be too conservative in their estimates, in my view. Moreover, some investors will probably feel that Wall Street is being too liberal in their estimates because they themselves feel cautious given Nvidia's humongous size. Yes, this caution among many investors would likely slow down Nvidia stock's rise, but that's better than the stock frequently shooting up to unsustainable levels, only to plunge back down to Earth, in my opinion. This topic could be several articles, so here's just a brief list. 1. The company's now-annual cadence of launching new graphics processing unit (GPU) architectures for its products for its AI-accelerated data center, gaming, and other market platforms. Blackwell is its current architecture. 2. The approach of the widespread legalization of autonomous vehicles. Nvidia's GPUs will be the "brains" inside many of these vehicles. 3. The approach of the era of humanoid robots. Nvidia's GPUs will be the "brains" inside many of these robots. 4. The company will stay ahead of the innovation pack by entering emerging new technologies via organic growth and acquisitions. An example here is quantum computing, in which I think Nvidia will be increasingly involved. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Beth McKenna has positions in Nvidia. The Motley Fool has positions in and recommends Amazon, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Could the "Next Nvidia Stock" Actually Be... Nvidia Stock? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
37 minutes ago
- Yahoo
Is Textron Stock Underperforming the Nasdaq?
Valued at a market cap of $13.8 billion, Textron Inc. (TXT) is a multi-industry company that leverages its global network of aircraft, defense, industrial, and finance businesses to provide customers with various solutions and services. The Providence, Rhode Island-located company operates in six segments: Textron Aviation, Bell, Textron Systems, Industrial, Textron eAviation, and Finance. Companies valued at $10 billion or more are generally classified as 'large-cap' stocks, and Textron fits this description perfectly. The company owns well-known brands like Bell Helicopters, Cessna, and Beechcraft aircraft, and Textron Systems. Dear Tesla Stock Fans, Mark Your Calendars for June 30 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Nvidia Is Quickly Approaching a New Record High. Is It Too Late to Buy NVDA Stock? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Textron stock has declined 19% from its 52-week high of $94.57. TXT stock has risen 3.2% over the past three months, lagging behind the broader Nasdaq Composite ($NASX), which increased 11.7% during the same period. In the longer term, TXT stock has marginally increased on a YTD basis, underperforming NASX's 1.2% return. Additionally, shares of Textron have dropped 10.9% over the past 52 weeks, compared to NASX's 9.4% gain over the same period. The stock has been trading below its 200-day moving average since late October last year. However, it has climbed above its 50-day moving average since May. Textron stock rose 2.6% following the release of its strong Q1 2025 results on Apr. 24. The company reported revenue of $3.3 billion, up 5.5% from the same quarter last year, surpassing the consensus estimate. Growth was primarily led by the Bell segment, which jumped 35.2%, driven by robust performance in both military and commercial product lines. Meanwhile, its adjusted EPS came in at $1.28, up 6.7% year-over-year, exceeding analysts' expectations. TXT reaffirmed its full-year 2025 adjusted EPS guidance of $6 to $6.20. Compared to its rival, L3Harris Technologies, Inc. (LHX) has outperformed TXT stock. LHX stock has increased 11.9% over the past 52 weeks and 18.3% on a YTD basis. Despite TXT's underperformance relative to the Nasdaq, analysts are moderately optimistic about its prospects. Among the 14 analysts covering the stock, there is a consensus rating of 'Moderate Buy,' and it is currently trading below the mean price target of $86.71. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
41 minutes ago
- Yahoo
Tesla's $56K India Gamble: Will the Model Y Sell in a Price-Sensitive Market?
Tesla (NASDAQ:TSLA) is finally hitting the accelerator in India. After years of back-and-forth, the EV giant is opening its first showroom in Mumbai this July, followed by another in New Delhi. It's starting with the Model Yshipped straight from its Shanghai plantmarking the company's first official sales push into the world's third-largest car market. Internal documents and people familiar with the matter confirm that Tesla has also brought in Supercharger hardware, car accessories, and parts from the US, China, and the Netherlandslaying the groundwork for a broader rollout. This move follows Elon Musk's February meeting with Indian Prime Minister Narendra Modi and could signal the start of a long-term India strategy. But it won't be an easy ride. Each Model Y imported was declared at just under $32,000, but racked up over $25,000 in import duties due to India's 70% tariff on fully-built EVs. Final sticker price? North of $56,000 before tax and insurancenearly 50% more than the U.S. price post-incentives. For a market where EVs still make up just 5% of new car sales and luxury vehicles are under 2%, Tesla will need more than brand power to spark volume. Still, the company is quietly building momentum. It's securing warehouse space in Karnataka and Gurugram, boosting hiring across charging, retail, and policy teams, and sending execs from abroad to oversee showroom setup in luxury districts. The early signs point to a premium positioning play aimed at affluent Indian buyers. Whether that strategy holdsor pivotswill depend on how fast Tesla can shift from imports to local production. For now, it's a high-stakes, high-margin experiment in one of the world's fastest-growing auto markets. This article first appeared on GuruFocus.
